Literature DB >> 17409938

Impact of a multidisciplinary thoracic oncology clinic on the timeliness of care.

Richard F Riedel1, Xiaofei Wang, Meg McCormack, Eric Toloza, Gustavo S Montana, Gilbert Schreiber, Michael J Kelley.   

Abstract

BACKGROUND: Multidisciplinary clinics have been recommended for the evaluation of patients with lung cancer. Evidence to support this recommendation, however, is limited. A single-center, retrospective review of lung cancer patients at a Veterans Affairs hospital was performed comparing timeliness of diagnostic and treatment decisions during the operation of a multidisciplinary thoracic oncology clinic (MTOC) with a period after it closed (non-MTOC), during which only a weekly multidisciplinary conference was held.
METHODS: Patients were identified from a tumor registry. Manual chart reviews were performed on all patients. Outcome measures included time from initial presentation to diagnosis (TTD) and time from diagnosis to treatment initiation (TTT).
RESULTS: Three hundred forty-five patients (244 in MTOC, 101 in non-MTOC) diagnosed with lung cancer between 1999 and 2003 were included in the study. Baseline characteristics were similar between the two groups. Median TTD was 48 days (95% confidence interval [CI]: 37-61) and 47 days (95% CI: 39-55) in the MTOC (n = 164) and non-MTOC cohorts (n = 89), respectively (p = 0.09). Median TTT was 22 days (95% CI: 20-27) and 23 days (95% CI: 20-34) in the MTOC (n = 165) and non-MTOC cohorts (n = 89), respectively (p = 0.71). There was no difference in overall survival.
CONCLUSION: Retrospective comparison of sequential cohorts failed to reveal benefit in the timeliness of care measures during the time period of MTOC operation. Potential confounders include the absence of a surgeon in the MTOC setting, an ongoing weekly multidisciplinary conference in the non-MTOC cohort, and existing infrastructures based on previous MTOC experiences and past provider experience. Confirmation of these findings in other health care settings is warranted, preferably in a prospective fashion.

Entities:  

Mesh:

Year:  2006        PMID: 17409938

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  19 in total

1.  Implementing effective and sustainable multidisciplinary clinical thoracic oncology programs.

Authors:  Raymond U Osarogiagbon; Richard K Freeman; Mark J Krasna
Journal:  Transl Lung Cancer Res       Date:  2015-08

Review 2.  Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.

Authors:  Nico van Zandwijk; Christopher Clarke; Douglas Henderson; A William Musk; Kwun Fong; Anna Nowak; Robert Loneragan; Brian McCaughan; Michael Boyer; Malcolm Feigen; David Currow; Penelope Schofield; Beth Ivimey Nick Pavlakis; Jocelyn McLean; Henry Marshall; Steven Leong; Victoria Keena; Andrew Penman
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

Review 3.  Treatment of limited disease small cell lung cancer: the multidisciplinary team.

Authors:  Markus Glatzer; Achim Rittmeyer; Joachim Müller; Isabelle Opitz; Alexandros Papachristofilou; Ioannis Psallidas; Martin Früh; Diana Born; Paul Martin Putora
Journal:  Eur Respir J       Date:  2017-08-24       Impact factor: 16.671

4.  Do multidisciplinary meetings follow guideline-based care?

Authors:  Shalini K Vinod; Mark A Sidhom; Geoff P Delaney
Journal:  J Oncol Pract       Date:  2010-11       Impact factor: 3.840

5.  Timeliness of Care and Lung Cancer Tumor-Stage Progression: How Long Can We Wait?

Authors:  Amelia W Maiga; Stephen A Deppen; Rhonda Pinkerman; Carol Callaway-Lane; Pierre P Massion; Robert S Dittus; Eric S Lambright; Jonathan C Nesbitt; David Baker; Eric L Grogan
Journal:  Ann Thorac Surg       Date:  2017-10-21       Impact factor: 4.330

6.  "All boats will rise": Physicians' perspectives on multidisciplinary lung cancer care in a community-based hospital setting.

Authors:  Satish K Kedia; Kenneth D Ward; Andy C Collins; Bianca M Jackson; Fedoria Rugless Stewart; Nicholas R Faris; Kristina S Roark; Raymond U Osarogiagbon
Journal:  Support Care Cancer       Date:  2019-07-15       Impact factor: 3.603

7.  Timeliness of care and prognosis in patients with lung cancer.

Authors:  F J Gonzalez-Barcala; J A Falagan; J M Garcia-Prim; L Valdes; J M Carreira; A Puga; P Martín-Lancharro; M T Garcia-Sanz; D Anton-Sanmartin; J C Canive-Gomez; A Pose-Reino; R Lopez-Lopez
Journal:  Ir J Med Sci       Date:  2013-10-04       Impact factor: 1.568

8.  Lung cancer diagnostic and treatment intervals in the United States: a health care disparity?

Authors:  Jeffrey T Yorio; Yang Xie; Jingsheng Yan; David E Gerber
Journal:  J Thorac Oncol       Date:  2009-11       Impact factor: 15.609

9.  Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  David E Ost; Sai-Ching Jim Yeung; Lynn T Tanoue; Michael K Gould
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

10.  Lung Cancer Strategist Program: A novel care delivery model to improve timeliness of diagnosis and treatment in high-risk patients.

Authors:  William W Phillips; Jessica Copeland; Sophie C Hofferberth; Julee R Armitage; Sam Fox; Margaret Kruithoff; Claire de Forcrand; Paul J Catalano; Christopher S Lathan; Joel S Weissman; David D Odell; Yolonda L Colson
Journal:  Healthc (Amst)       Date:  2021-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.